Viewpoints: When Pills Change Appearance, Patients Get Confused; White House Guts Harm Reduction Funding
Opinion writers tackle these public health topics.
Archives: Morning Breakouts
1 - 20 of 112,219 Results
-
-
Longer Looks: Interesting Reads You Might Have Missed
Each week, KFF Health News finds longer stories for you to read. Today's selections are on cancer testing, mental health, hantavirus, alcohol treatment, and more.
-
California Warns Of Two Air Toxins With Elevated Cancer Risks
Officials from the California Office of Environmental Health Hazard Assessment shared data showing the levels of acrolein and ethylene oxide in the ambient air are much stronger than previously thought.
-
The World Is Missing Its Targets On Public Health Goals, WHO Reports
The World Health Organization's annual health statistics report explains that less international aid from wealthy countries has disrupted medical services and weakened disease surveillance. This, along with the lasting impacts of the COVID-19 pandemic, is contributing to many dying of preventable causes, CIDRAP reports.
-
Survey Finds Physicians Doubt Insurers’ Pledge To Ease Prior Authorization Woes
Most doctors who took the survey say that mandatory prior authorizations have increased over the past five years. Only 1 in 3 say that insurance companies' pledge to smooth the process will make a "meaningful" difference.
-
Justice Department Not Privy To Private Trans Patient Data, Judge Rules
“DOJ has proven unworthy of this trust at every point in this case,” U.S. District Judge Mary McElroy wrote in her ruling blocking the administration from getting information from Rhode Island’s largest hospital that provides gender-affirming care to minors. The Department of Justice plans to appeal.
-
CDC: No Current US Cases Of Hantavirus, But 41 People Are Being Monitored
The tally of those being monitored post-exposure is higher than previously thought, MedPage Today reports. Also: An American oncologist who was traveling on the cruise ship and helped care for fellow passengers is cleared to leave a special biocontainment unit in Nebraska, AP reports.
-
Supreme Court Preserves Telehealth And Mail Access To Mifepristone — For Now
The court intervened at the behest of two manufacturers of mifepristone on Thursday, after the U.S. Court of Appeals for the Fifth Circuit restricted access to the drug nationwide. The order means that the Fifth Circuit’s decision will remain blocked while litigation continues in the lower courts. The issue could eventually return to the high court.
-
First Edition: Friday, May 15, 2026
Today's early morning highlights from the major news organizations.
By khnkit -
Viewpoints: FDA Has Opportunity To Reboot After Makary Exit; Hantavirus Outbreak Reveals Detection Gap
Editorial writers delve into these public health issues.
By khnelysiag -
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
Each week, KFF Health News compiles a selection of health policy studies and briefs.
-
Bipartisan Initiative To Cap Insulin Costs, Increase Coverage Becomes Law In Virginia
New measures signed by Gov. Abigail Spanberger, a Democrat, limit the out-of-pocket cost of insulin to $35 and expand what insurance plans must cover. The laws go into effect July 1. Also: Iowa enacts prior authorization reform; and more.
-
National Study Underscores Disparities In State-Level HPV Vaccine Uptake
An analysis of the 2023 National Immunization Survey-Teen found that states in the Northeast census region had significantly higher odds of HPV vaccine uptake, while states in the South had significantly lower odds, CIDRAP reports. The HPV vaccine is credited with lowering the cervical cancer risk by 80% in women vaccinated by age 16 and by 66% in those vaccinated after 16.
-
Doctors Report More Burnout Than Nurses Around AI Use In Healthcare
Fierce Healthcare reports that nurses feel they have more time with patients and are more accepting of AI in the workplace. Doctors, on the other hand, are more skeptical of new technologies, as they already feel overburdened and lack the time to adjust to the latest technology.
-
US Drug Overdose Deaths Continue To Fall, Dropping Nearly 14% In 2025
The Wall Street Journal reports that deaths have declined for three years in a row, falling to prepandemic levels, according to preliminary data from the CDC released Wednesday. Also in public health news: alcohol's effect on the body, poisonous wild mushrooms in California, parkour for older adults, and more.
-
CMS Freezes Medicare Home Health, Hospice Provider Sign-Ups For 6 Months
Modern Healthcare reports that the pause is part of the agency's latest effort to address fraud in the healthcare system. Also: CMS rolls out prior authorization plan; news outlets continue their coverage on Marty Makary's exit from the FDA; and more.
-
CDC ‘Encouraging’ But Not Requiring Cruisegoers Exposed To Hantavirus To Isolate At Home
The Hill reports on messaging out of the CDC, including that "the risk to the general public is low." Also: why germs spread on cruise ships and how parents can discuss hantavirus with children.
-
First Edition: Thursday, May 14, 2026
Today's early morning highlights from the major news organizations.
By khnkit -
Viewpoints: Kennedy’s Misguided Push Against Antidepressants; Why Do We Keep Getting Virus Spread Wrong?
Opinion writers examine these public health issues.
By khnelysiag -
A Drug’s Rocky Road To Discovery May Signal Pancreatic Cancer Breakthrough
The New York Times reports on daraxonrasib, the first drug to substantially extend the lives of patients with pancreatic cancer. The cellular proteins it targets fuel the three leading causes of cancer deaths: pancreatic tumors, lung, and colon cancers. The drug is fast-tracked for review by the Food and Drug Administration and could win approval later this year.